Vista Point bankers provide thoughts and insights into technology M&A, transactions and their implications, and the world of boutique investment banking

Category Archives: Healthcare

Procura Acquires Igea Home Healthcare Software

Vista Point Advisors is pleased to announce the acquisition of Igea Home Healthcare Software by Procura. Vista Point Advisors acted as the exclusive financial advisor to Igea Home Healthcare Software. Press Release About Igea Home Healthcare Software: Igea Home Healthcare Software is an industry leader in SaaS solutions for the home health market. The Company’s

Read More

Thoughts on “The Fatal Flaw in Underwriter Selection”

Earlier today, an article was published on PeHub regarding the mistake that many companies and VCs make when hiring investment banks for an IPO process.  Timothy Keating, the writer, states that the primary reason for the underperformance by the bulge bracket banks on IPOs is due to the disconnect in their IPO clients vs. their

Read More

Thoughts on Roche / CMI

Roche purchased Constitutional Medical Investors (“CMI”), a Boston-based blood diagnostics business for $220m in upfront cash plus additional incentive payments based on undisclosed milestones.   CMI’s Bloodhound is a compact blood diagnostic platform that tests for diseases which include anemia and leukemia. This is a great transaction for Roche as it strengthens their position in the

Read More

Thoughts on Thermo Fisher / Life Technologies

Thermo Fisher’s $13.6 billion acquisition of Life Tech has largely been a validation for Ion Torrent, Life Tech’s next-generation sequencing business, which Life Tech acquired in 2010 for ~$725m.  Although Life Tech has several businesses across life sciences (specialty diagnostics, lab tools, biological consumables, etc.), this deal is the clearest indication that large-cap diagnostics players

Read More

Vista Point Advisors Quarterly M&A Updates

Download All